Metabolic – Cell Power

Metabolic Disorders or Diseases

The following section lists major devlopment along the innovative drug route.

Click horizontal tabs above for more information.

Company *product

IND

Phase I

Phase II

Phase III

Reprogenix Technology
*RGB-5088

EndoCell Therapeutics
*E-islet 01

Betacure Therapeutics
*BCP601

Company *product

IND

Phase I

Phase II

Phase III

Reprogenix Tech.
*RGB-5088
*SC-derived islts

Jiyuan Biotech.
*Autologous, gene-modified, FGF21+ & GLP1+ MSC
*http://www.jiyuanbio.com.cn/p/43

RMBio Tech.
*HF001 (MSC)

Doublle Bioproduct
*E101 (MSC)
*https://www.gzdoublle.com/lczm.html

End of Section

The following section lists major development along the innovatie biomedical technology route.

Click horizontal tabs above for more information.

Hospitals *biomedical tech

Clinical Study

Approved

Tianjin First Central Hospital (Tianjin)
*ChiPSC-derived islts
https://www.tj-fch.com/system/2025/12/19/030181643.shtml

Shanghai Ruijin Hospital (Shanghai )
*Expanded adult islets

The 3rd Affiliated Hospital of Sun Yat-Sen University (Guangzhou)
*MSC

Hospitals *biomedical tech

Clinical Study

Approved

Peking Union Medical College Hospital (Beijing)
*cell?

Shanghai Ruijin Hospital (Shanghai )
*Autologous, gene-modified, FGF21+ & GLP1+ MSC

End of Section